<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2022-67-2-20-27</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-1614</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Современные возможности профилактики прогрессирования хронической болезни почек у детей</article-title><trans-title-group xml:lang="en"><trans-title>Current opportunities for prevention of chronic kidney disease progression in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1120-4602</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полканова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Polkanova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полканова Валерия Александровна — соискатель кафедры детских болезней</p><p>443099 Самара, ул. Чапаевская, д. 89</p></bio><bio xml:lang="en"><p>Samara</p></bio><email xlink:type="simple">valeriya.polkanova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7943-325X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронина</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Voronina</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воронина Евгения Николаевна — к.м.н., асс. кафедры детских болезней</p><p>443099 Самара, ул. Чапаевская, д. 89</p></bio><bio xml:lang="en"><p>Samara</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5869-2893</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Печкуров</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pechkurov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Печкуров Дмитрий Владимирович — д.м.н., проф., зав. кафедрой детских болезней</p><p>443099 Самара, ул. Чапаевская, д. 89</p></bio><bio xml:lang="en"><p>Samara</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Самарский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Samara State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>06</month><year>2022</year></pub-date><volume>67</volume><issue>2</issue><fpage>20</fpage><lpage>27</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/1614">https://www.ped-perinatology.ru/jour/article/view/1614</self-uri><abstract><p>Хроническая болезнь почек — актуальная проблема детского возраста, интерес к которой возрастает, с одной стороны, в связи с ростом числа детей с хронической болезнью почек и затрат системы общественного здравоохранения, а с другой стороны — возросшими возможностями ранней диагностики и профилактики прогрессирования этого состояния. В связи с этим актуальны исследования в области ренопротекции — комплексом мер сопроводительной терапии, способствующей сохранению функции почек, а в случае развившейся хронической почечной недостаточности — поддержанию их остаточной функции. Ренопротективная стратегия у детей и взрослых имеет отличия, что связано со своеобразием причин хронической болезни почек и возрастными особенностями физиологии и патологии систем организма.  </p></abstract><trans-abstract xml:lang="en"><p>Chronic kidney disease is an urgent problem of childhood getting more and more interest on the one hand due to the higher incidence among children and the increased public health expenditures, and on the other hand due to the expanding opportunities for early diagnosis and prevention of the progression of this condition. Renoprotection means a set of measures of accompanying therapy that helps to preserve renal function, and in the case of advanced chronic renal failure — to maintain their residual function. The renoprotective strategy in children differs from that in adults, which is associated with the peculiarity of the causes of chronic kidney disease and the age-related characteristics of the physiology and pathology of body systems.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>хроническая болезнь почек</kwd><kwd>профилактика прогрессирования</kwd><kwd>ренопротекция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>chronic kidney disease</kwd><kwd>progression prevention</kwd><kwd>renoprotection</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hill N.R., Fatoba S.T., Oke J.L., Samuel T., Oke J.L., Hirst J.A. et al. Global Prevalence of Chronic Kidney Disease — Systematic Review and Meta-analysis. PLoS One 2016; 11(7): e0158765. DOI: 10,1371/journal.pone.0158765</mixed-citation><mixed-citation xml:lang="en">Hill  N.R., Fatoba  S.T., Oke  J.L., Samuel  T., Oke  J.L., Hirst  J.A. et  al. Global Prevalence of Chronic Kidney Disease — Systematic Review and Meta-analysis. PLoS One 2016; 11(7): e0158765. DOI: 10,1371/journal.pone.0158765</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hogg R.J., Furth S., Lemley K.V., Portman R., Schwartz G.J., Coresh J. et al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and’ adolescents: evaluation, classification and stratification. Pediatrics 2003; 3(6): 1416–1421</mixed-citation><mixed-citation xml:lang="en">Hogg R.J., Furth S., Lemley K.V., Portman R., Schwartz G.J., Coresh  J. et  al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and’ adolescents: evaluation, classification and stratification. Pediatrics 2003; 3(6): 1416–1421</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">North American Pediatric Renal Transplant Cooperative Study (NARPTCS) 2008 Annual report. The EMMES Corporation, Rockville, MD. https://www.nejm.org/doi/full/10,1056/NEJM199206253262602. Ссылка активна на 15.01.2021.</mixed-citation><mixed-citation xml:lang="en">North American Pediatric Renal Transplant Cooperative Study (NARPTCS) 2008 Annual report. The EMMES Corporation, Rockville, MD. https://www.nejm.org/doi/full/10,1056/NEJM199206253262602. Ссылка активна на 15.01.2021.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Weaver D.J., Somers M.J.G., Martz K., Mitsnefes M.M. Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry. Pediatr Nephrol 2017; 32(12): 2319–2330. DOI: 10,1007/s00467–017–3759–4</mixed-citation><mixed-citation xml:lang="en">Weaver D.J., Somers M.J.G., Martz K., Mitsnefes M.M. Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry. Pediatr Nephrol 2017; 32(12): 2319–2330. DOI: 10,1007/s00467–017–3759–4</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Лысова Е.В. Этиологическая структура хронической болезни почек у детей и подростков Педиатр 2016; 7(2): 204–205.</mixed-citation><mixed-citation xml:lang="en">Lysova  E.V. The etiological structure of chronic kidney disease in children and adolescents. Pediatriya 2016; 7(2): 204–205. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Лысова Е.В., Савенкова Н.Д. CAKUT-синдром в этиологической структуре хронической болезни почек у детей и подростков. Нефрология 2017; 21(3): 69–74.</mixed-citation><mixed-citation xml:lang="en">Lysova E.V., Savenkova N.D. CAKUT-syndrome in the etiological structure of chronic kidney disease in children and adolescents, Nefrologiya 2017; 21(3): 69–74. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Зорин И.В., Вялкова А.А. Профилактика прогрессирования хронической болезни почек у детей с рефлюкс-нефропатией. Лечащий врач 2015; 1: 59.</mixed-citation><mixed-citation xml:lang="en">Zorin  I.V., Vyalkova  A.A. Prevention of the progression of chronic kidney disease in children with reflux nephropathy. Lechashhii vrach 2015; 1: 59. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Томилина Н.А., Андрусев А.М., Перегудова Н.Г., Шинкарева М.Б. Заместительная терапия терминальной хронической почечной недостаточности в Российской Федерации в 2010–2015 г. Отчет по данным Общероссийского регистра заместительной почечной терапии Российского диализного общества. Часть первая. Нефрология и диализ 2017; 4(19): 1–95.</mixed-citation><mixed-citation xml:lang="en">Tomilina N.A., Andrusev A.M., Peregudova  N.G., Shinkareva  M.B. Substitution therapy of terminal chronic renal failure in the Russian Federation in 2010–2015. Report on the data of the All-Russian Register of Renal Substitution Therapy of the Russian Dialysis Society. Part one. Nefrologiya i Dializ 2017; 4(19): 1–95. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология 2012; 16(1): 89–115.</mixed-citation><mixed-citation xml:lang="en">National recommendations. Chronic kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches. Nefrologiya 2012; 16(1): 89–115. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатова М.С. Вопросы профилактики развития и прогрессирования хронических болезней почек у детей. Российский вестник перинатологии и педиатрии. 2009; 54(5): 6–13.</mixed-citation><mixed-citation xml:lang="en">Ignatova M.S. Prevention of the development and progression of chronic kidney disease in children. Rossiyskiy vestnik perinatologii i pediatrii 2009; 54(5): 6–13. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Вялкова А.А., Зорин И.В., Чеснокова С.А., Плотникова С.В. Ранняя диагностика хронической болезни почек у детей. Нефрология 2019; 23(6): 135–136.</mixed-citation><mixed-citation xml:lang="en">Vyalkova  A.A., Zorin  I.V., Chesnokova  S.A., Plotnikova  S.V. Early diagnosis of chronic kidney disease in children. Nefrologiya 2019; 23(6): 135–136. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Комарова О.В., Кучеренко А.Г., Смирнов И.Е., Цыгин А.Н. Роль апоптоза в прогрессировании хронической болезни почек у детей. Нефрология и диализ 2013; 15(4): 375.</mixed-citation><mixed-citation xml:lang="en">Komarova O.V., Kucherenko A.G., Smirnov I.E., Tsygin A.N. The role of apoptosis in the progression of chronic kidney disease in children. Nefrologiya i dializ 2013; 15(4): 375. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Краснов М.В., Макарова Т.А., Краснов В.М. Современные представления о заболеваниях почек у детей и принципы терапии. В сборнике: Актуальные проблемы детской уронефрологии. Материалы Межрегиональной научно-практической конференции, посвященной 230-летию со дня рождения основателя нефрологии Ричарда Брайта. Чувашский государственный университет имени И.Н. Ульянова, Чувашское региональное отделение «Союз педиатров России». 2019:26–44.</mixed-citation><mixed-citation xml:lang="en">Krasnov  M.V., Makarova  T.A., Krasnov  V.M. Modern concepts of kidney disease in children and the principles of therapy. In the collection: Actual problems of pediatric uronephrology. Materials of the Interregional Scientific and Practical Conference dedicated to the 230th anniversary of the birth of the founder of nephrology, Richard Bright. Chuvash State University named after I.N. Ulyanova, Chuvash regional branch of the Union of Pediatricians of Russia. 2019: 26–44. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Отрощенко Е.С., Леонова Л.В., Комарова О.В., Тимофеева А.Г., Цыгин А.Н. Эффективность комбинированной фармакологической блокады ренин-ангиотензин-альдостероновой системы у детей с хронической болезнью почек. Педиатрическая фармакология 2010; 7(2): 105–109.</mixed-citation><mixed-citation xml:lang="en">Otroshchenko E.S., Leonova L.V., Komarova O.V., Timofeeva  A.G., Tsygin  A.N. The effectiveness of the combined pharmacological blockade of the renin-angiotensin-aldosterone system in children with chronic kidney disease. Pediatricheskaya farmakologiya 2010; 7(2): 105–109. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Настаушева Т.Л., Жданова О.А., Настаушева Н.С., Минакова О.В., Звягина Т.Г., Стахурлова Л.И. и др. Физическое развитие детей при хронической болезни почек, обусловленной рецидивирующим пиелонефритом. Вопросы практической педиатрии 2016; 11(3): 14–21.</mixed-citation><mixed-citation xml:lang="en">Nastausheva  T.L., Zhdanova  O.A., Nastausheva  N.S., Minakova  O.V., Zvyagina  T.G., Stakhurlova  L.I. et  al. Physical development of children with chronic kidney disease caused by recurrent pyelonephritis. Voprosy` prakticheskoi pediatrii 2016; 11(3): 14–21. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fried L.F., Emanuele N., Zhang J.H., Brophy M., Conner T.A., Duckworth W. et al.; VA NEPHRON-D Investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 2013; 369(20): 1892–1903. DOI: 10,1056/NEJMoa1303154</mixed-citation><mixed-citation xml:lang="en">Fried L.F., Emanuele N., Zhang J.H., Brophy M., Conner T.A., Duckworth  W. et  al.; VA NEPHRON-D Investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 2013; 369(20): 1892–1903. DOI: 10,1056/NEJMoa1303154</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mann J.F., Schmieder R.E., McQueen M., Dyal L., Schumacher H., Pogue J. et al; ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008; 372(9638): 547–553. DOI: 10,1016/S0140–6736(08)61236–2. PMID: 18707986</mixed-citation><mixed-citation xml:lang="en">Mann  J.F., Schmieder  R.E., McQueen  M., Dyal  L., Schumacher  H., Pogue  J. et al; ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008; 372(9638): 547–553. DOI: 10,1016/S0140–6736(08)61236–2. PMID: 18707986</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kohan D.E., Barton M. Endothelin and endothelin antagonists in chronic kidney disease. Kidney Int 2014; 86(5): 896– 904. DOI: 10,1038/ki.2014,143</mixed-citation><mixed-citation xml:lang="en">Kohan  D.E., Barton  M. Endothelin and endothelin antagonists in chronic kidney disease. Kidney Int 2014; 86(5): 896– 904. DOI: 10,1038/ki.2014,143</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vilayur E., Harris D.C. Emerging therapies for chronic kidney disease: what is their role? Nat Rev Nephrol 2009; 5(7): 375–383. DOI: 10,1038/nrneph.2009,76.</mixed-citation><mixed-citation xml:lang="en">Vilayur  E., Harris  D.C. Emerging therapies for chronic kidney disease: what is their role? Nat Rev Nephrol 2009; 5(7): 375–383. DOI: 10,1038/nrneph.2009,76.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Аксенова М.Е. Патология сердечно-сосудистой системы у детей с хроническими болезнями почек: эпидемиология, факторы риска, патогенез. Российский вестник перинатологии и педиатрии 2015; 60(2): 22–28.</mixed-citation><mixed-citation xml:lang="en">Aksenova  M.E. Pathology of the cardiovascular system in children with chronic kidney disease: epidemiology, risk factors, pathogenesis. Rossiyskiy vestnik perinatologii i pediatrii 2015; 60(2): 22–28. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Нефрология: национальное руководство под ред. Н.А. Мухина. М.: ГЭОТАР-Медиа 2009: 720 с.</mixed-citation><mixed-citation xml:lang="en">Nephrology: national guidelines edited by O.N. Mukhina. M.: GEOTAR-Media, 2009; 720. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pediatric Nephrology. Editors Avner E.D., Harmon W.E., Niaudet P. Philadelphia: Lippincott Williams &amp; Wilkins, 2004; 1564</mixed-citation><mixed-citation xml:lang="en">Pediatric Nephrology. Editors Avner E.D., Harmon W.E., Niaudet P. Philadelphia: Lippincott Williams &amp; Wilkins, 2004; 1564</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Pediatric nephrology. Editors Rees L., Webb N., Brogan P. London: Oxford University Press, 2007; 618</mixed-citation><mixed-citation xml:lang="en">Pediatric nephrology. Editors Rees L., Webb N., Brogan P. London: Oxford University Press, 2007; 618</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Маковецкая Г.А., Мазур Л.И., Терехин С.С. Хроническая болезнь почек у детей с врожденными обструктивными уропатиями: профилактика прогрессирования. Самара: Ас Гард, 2014; 154.</mixed-citation><mixed-citation xml:lang="en">Makovetskaya  G.A., Mazur  L.I., Terekhin S.S. Chronic kidney disease in children with congenital obstructive uropathy: prevention of progression. Samara: As Gard, 2014; 154. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Аборин С.В. Острое повреждение почек у недоношенных новорожденных: клиническое значение, механизм развития, возможности ранней диагностики. Аспирантский вестник Поволжья 2016; 1(2): 44–50.</mixed-citation><mixed-citation xml:lang="en">Aborin  S.V. Acute kidney injury in premature infants: clinical significance, mechanism of development, early diagnosis. Aspirantskii vestnik Povolzh`ya 2016; 1(2): 44–50. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Чичуга Е.М., Настаушева Т.Л., Звягина Т.Г. Маркеры хронической болезни почек у детей с обструкцией мочевых путей или пузырно-мочеточниковым рефлюксом. Педиатрическая фармакология 2015; 12(4): 407–413.</mixed-citation><mixed-citation xml:lang="en">Chichuga  E.M., Nastausheva  T.L., Zvyagina  T.G. Markers of chronic kidney disease in children with urinary tract obstruction or vesicoureteral reflux. Pediatricheskaya farmakologiya 2015; 12(4): 407–413. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Кольбе О.Б., Моисеев А.Б., Труфанова А.В., Зубавина М.Н. Бадяева С.А. Возможности допплерографического исследования почечных сосудов для оптимизации нефропротективной терапии у детей с аномалиями почек и коррегированными обструктивными уропатиями. Педиатрия. Журнал им. Г.Н. Сперанского. 2011; 90(3): 29–34.</mixed-citation><mixed-citation xml:lang="en">Kolbe  O.B., Moiseev  A.B., Trufanova  A.V., Zubavina M.N., Badyaeva  S.A. et  al. Possibilities of Doppler study of renal vessels for optimization of nephroprotective therapy in children with renal anomalies and corrected obstructive uropathies. Pediatriya. Zhurnal im. G.N. Speranskogo 2011; 90(3): 29–34. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Лысова Е.В., Савенкова Н.Д. Лечение синдрома анемии у детей с хронической болезнью почек. Нефрология 2015; 19(3): 20–31.</mixed-citation><mixed-citation xml:lang="en">Lysova E.V., Savenkova N.D. Treatment of anemia syndrome in children with chronic kidney disease. Nefrologiya 2015; 19(3): 20–31. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Avram M.M. An introduction and overview to new therapeutic approaches to the management of renal disease. Kidney Int 2006; 70: 1–3</mixed-citation><mixed-citation xml:lang="en">Avram M.M. An introduction and overview to new therapeutic approaches to the management of renal disease. Kidney Int 2006; 70: 1–3</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Neuen B.L., Jardine M.J., Perkovic V. Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future? Nephrol Dial Transplant 2020; 35(Suppl 1): i48–i55. DOI: 10,1093/ndt/gfz252</mixed-citation><mixed-citation xml:lang="en">Neuen  B.L., Jardine  M.J., Perkovic  V. Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future? Nephrol Dial Transplant 2020; 35(Suppl 1): i48–i55. DOI: 10,1093/ndt/gfz252</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Zhong J., Yang H.C., Fogo A.B. A perspective on chronic kidney disease progression. Am J Physiol Renal Physiol 2017; 312(3): F375–F384. DOI: 10,1152/ajprenal.00266,2016</mixed-citation><mixed-citation xml:lang="en">Zhong J., Yang H.C., Fogo A.B. A perspective on chronic kidney disease progression. Am J Physiol Renal Physiol 2017; 312(3): F375–F384. DOI: 10,1152/ajprenal.00266,2016</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Chin M.P., Bakris G.L., Block G.A., Chertow G.M., Goldsberry A., Inker L.A. et al. Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study. Am J Nephrol 2018; 47(1): 40– 47. DOI: 10,1159/000486398</mixed-citation><mixed-citation xml:lang="en">Chin M.P., Bakris G.L., Block G.A., Chertow G.M., Goldsberry A., Inker L.A. et al. Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study. Am J Nephrol 2018; 47(1): 40– 47. DOI: 10,1159/000486398</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Шавлохова Э.А., Харебова Ф.Ю. Рамиприл у больных с диабетической нефропротекцией. В книге: Артериальная гипертония 2017 как междисциплинарная проблема. Сборник тезисов XIII Всероссийского конгресса. ООО «ИнтерМедсервис». Москва. 2017; 83–84.</mixed-citation><mixed-citation xml:lang="en">Shavlokhova  E.A., Kharebova  F.Yu. Ramipril in patients with diabetic nephroprotection. In the book: Arterial hypertension 2017 as an interdisciplinary problem. Collection of abstracts of the XIII All-Russian Congress. OOO "InterMedservis". Moskva. 2017; 83–84 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов Д.Д. Диуретики и новые возможности в нефропротекции. Почки 2019; 8(1): 2–6.</mixed-citation><mixed-citation xml:lang="en">Ivanov D.D. Diuretics and new possibilities in nephroprotection. Pochki 2019; 8(1): 2–6. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Филипец Н.Д. Иванов Д.Д., Гоженко А.И. Блокаторы ренин-ангиотензин-альдостероновой системы как основное патогенетическое направление медикаментозной нефропротекции. Почки 2019; 8(1): 34–39</mixed-citation><mixed-citation xml:lang="en">Filipets N.D., Ivanov  D.D., Gozhenko  A.I. Blockers of the renin-angiotensin-aldosterone system as the main pathogenetic direction of drug nephroprotection. Pochki 2019; 8(1): 34–39. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Flynn J.T., Kaelber D.C., Baker-Smith C.M. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140: 61–75. DOI: 10,1542/peds.2017–1904</mixed-citation><mixed-citation xml:lang="en">Flynn J.T., Kaelber D.C., Baker-Smith C.M. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140: 61–75. DOI: 10,1542/peds.2017–1904</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Gallibois C., Jawa N., Noone D. Hypertension in pediatric patients with chronic kidney disease: management challenges. Int J Nephrol Renovasc Dis 2017; 10: 205–222. DOI: 10,2147/IJNRD.S100891</mixed-citation><mixed-citation xml:lang="en">Gallibois  C., Jawa  N., Noone  D. Hypertension in pediatric patients with chronic kidney disease: management challenges. Int J Nephrol Renovasc Dis 2017; 10: 205–222. DOI: 10,2147/IJNRD.S100891</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Мамбетова А.М. Инарокова А.М., Шабалова Н.Н., Бижева Д.В. Оценка влияния нефропротективной терапии ингибиторами ангиотензинпревращающего фермента на течение хронической болезни почек у детей с врожденными пороками развития органов мочевой системы. Нефрология 2019; 23(3): 59–64.</mixed-citation><mixed-citation xml:lang="en">Mambetova A.M. Inarokova A.M., Shabalova N.N., Bizheva D.V. Evaluation of the effect of nephroprotective therapy with angiotensin-converting enzyme inhibitors on the course of chronic kidney disease in children with congenital malformations of the urinary system. Nefrologiya 2019; 23(3): 59–64. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Маковецкая Г.А. Мазур Л.И. Балашова Е.А. Терехин С.С. Врожденные обструктивные уропатии у детей: нефропротективная стратегия. Педиатрия. Журнал им. Г.Н. Сперанского. 2017; 96(5): 38–43.</mixed-citation><mixed-citation xml:lang="en">Makovetskaya G.A., Mazur L.I., Balashova E.A., Terekhin S.S. Congenital obstructive uropathy in children: nephroprotective strategy. Pediatriya. Zhurnal im. G.N. Speranskogo 2017; 96(5): 38–43. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Приходина Л.С., Захарова И.Н. Прогрессирование заболеваний почек у детей: патогенез, факторы риска, терапия. Москва: РМАНПО, 2019: 77.</mixed-citation><mixed-citation xml:lang="en">Prikhodina  L.S., Zakharova  I.N. Progression of kidney disease in children: pathogenesis, risk factors, therapy. Moscow: RMANPO, 2019:77. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Баринов И.В., Маковецкая Г.А., Борисова О.В., Мазур Л.И. Клинико-иммунологические параллели при хронической почечной недостаточности у детей. Аллергология и иммунология в педиатрии 2020; 2(61): 41–48.</mixed-citation><mixed-citation xml:lang="en">Barinov I.V., Makovetskaya G.A., Borisova O.V., Mazur L.I. Clinical and immunological parallels in chronic renal failure in children. Allergologiya i immunologija v pediatrii 2020; 2(61): 41–48. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Баринов И.В., Борисова О.В. Прогнозирование формирования хронической болезни почек у детей, перенесших острое повреждение почек. Практическая медицина 2020; 18(3): 70–75.</mixed-citation><mixed-citation xml:lang="en">Barinov  I.V., Borisova  O.V. Prediction of the formation of chronic kidney disease in children with acute kidney injury. Prakticheskaya meditsina 2020; 18(3): 70–75. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Вакуленко Л.И. Эффективность нефропротекторной терапии у детей с хроническим пиелонефритом в катамнестическом наблюдении Здоровье ребенка 2018; 13(2): 165–170.</mixed-citation><mixed-citation xml:lang="en">Vakulenko  L.I. The effectiveness of nephroprotective therapy in children with chronic pyelonephritis in follow-up observation. Zdorov`e rebenka 2018; 13(2): 165–170. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Сергеева Т.В., Вознесенская Т.С., Картамышева Н.Н., Боровик Т.Э., Кутафина Е.К., Семенова Н.Н. и др. Диетотерапия при хронической болезни почек у детей. Российский педиатрический журнал 2014; 17(6): 23–27.</mixed-citation><mixed-citation xml:lang="en">Sergeeva T.V., Voznesenskaya T.S., Kartamysheva N.N., Borovik T.E., Kutafina E.K., Semenova N.N. et al. Diet therapy for chronic kidney disease in children. Rossiyskiy pediatricheskiy zhurnal 2014; 17(6): 23–27. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнова Н.Н., Сергеева К.М. Метаболический синдром и хроническая болезнь почек у детей и подростков. Профилактическая и клиническая медицина 2011; 3(40): 185–191.</mixed-citation><mixed-citation xml:lang="en">Smirnova  N.N., Sergeeva  K.M. Metabolic syndrome and chronic kidney disease in children and adolescents. Profilakticheskaya i klinicheskaya meditsina 2011; 3(40): 185–191. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Aparicio M., Cano N.J.M., Cupisti A., Ecder T., Fouque D., Garneata L. et al. KetoAcid Therapy in Predialysis Chronic Kidney Disease Patients: Consensus Statements. J Ren Nutr 2009; 19(5): 33–35. DOI: 10,1053/j.jrn.2011.09.006</mixed-citation><mixed-citation xml:lang="en">Aparicio  M., Cano  N.J.M., Cupisti  A., Ecder  T., Fouque  D., Garneata  L. et  al. KetoAcid Therapy in Predialysis Chronic Kidney Disease Patients: Consensus Statements. J Ren Nutr 2009; 19(5): 33–35. DOI: 10,1053/j.jrn.2011.09.006</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Giovannetti S., Maggiore Q. A low-nitrogen diet with protein of high biological value for severe chronic uraemia. Lancet 1964; 37: 1000(3): 91–119</mixed-citation><mixed-citation xml:lang="en">Giovannetti S., Maggiore Q. A low-nitrogen diet with protein of high biological value for severe chronic uraemia. Lancet 1964; 37: 1000(3): 91–119</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Завьялова А.Н., Гостимский А.В., Федорец В.Н. Диетологические подходы к ведению детей с хронической болезнью почек. Практическая медицина 2019; 17(5): 152– 160.</mixed-citation><mixed-citation xml:lang="en">Zavyalova  A.N., Gostimsky  A.V., Fedorets  V.N. Dietary approaches to the management of children with chronic kidney disease. Prakticheskaya meditsina 2019; 17(5): 152–160. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Chauveau P., Couzi L., Vendrely B., de Précigout V., Combe C., Fouque D., Aparicio M. Long-term outcome on renal replacement therapy in patients who previously received a keto acid-supplemented Very-low-protein diet. Am J Clin Nutr 2009; 90(4): 969–974. DOI: 10,3945/ajcn.2009,27980</mixed-citation><mixed-citation xml:lang="en">Chauveau P., Couzi L., Vendrely B., de Précigout V., Combe C., Fouque  D., Aparicio  M. Long-term outcome on renal replacement therapy in patients who previously received a keto acid-supplemented Very-low-protein diet. Am J Clin Nutr 2009; 90(4): 969–974. DOI: 10,3945/ajcn.2009,27980</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Мухин Н.А., Козловская Л.В., Фомин В.В., Милованов Ю.С. Исследование MDRD: значение для клинической нефрологии. Клиническая нефрология 2013; 4: 4–7.</mixed-citation><mixed-citation xml:lang="en">Mukhin N.A., Kozlovskaya L.V., Fomin V.V., Milovanov Yu.S. MDRD Research: Implications for Clinical Nephrology. Klinicheskaya nefrologiya 2013; 4: 4–7. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Сигитова О.Н., Архипов Е.В., Ким Т.Ю. Анализ эффективности нефропротекции с применением малобелковой диеты и кетоаналогов аминокислот у пациентов с хронической болезнью почек. Кардиология 2015; 55(9): 43–49.</mixed-citation><mixed-citation xml:lang="en">Sigitova  O.N., Arkhipov  E.V., Kim  T.Yu. Analysis of the effectiveness of nephroprotection using a low protein diet and keto analogs of amino acids in patients with chronic kidney disease. Kardiologiya 2015; 55(9): 43–49. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Фомина С., Багдасарова И. Ограничение белка в питании детей с хронической болезнью почек 3–4 стадии. Украiнський журнал нефрологii та дiалiзу. 2013; 3: 84–89.</mixed-citation><mixed-citation xml:lang="en">Fomina  S., Bagdasarova  I. Protein restriction in the diet of children with stage 3–4 chronic kidney disease. Ukrains`ki j zhurnal nefrologii ta dializu 2013; 3: 84–89. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Кушниренко С.В., Иванов Д.Д. Опыт применения незаменимых аминокислот и их кетоаналогов у детей с хронической болезнью почек. Почки. 2013; 1 (3): 35–38.</mixed-citation><mixed-citation xml:lang="en">Kushnirenko S.V., Ivanov D.D. Experience of using essential amino acids and their keto analogs in children with chronic kidney disease. Pochki 2013; 1(3): 35–38. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Петросян Э.К., Молчанова М.С. Хроническая болезнь почек. Детская нефрология. Под ред. В.П. Шумилова, Э.К. Петросян, О.Л. Чугуновой. М: МЕДпресс-информ 2018; 616.</mixed-citation><mixed-citation xml:lang="en">Petrosyan E.K., M.S. Molchanova. Chronic kidney disease. Pediatric nephrology. Editors Shumilova V.P., Petrosyan  E.K., Chugunova O.L. M: MEDpress-inform, 2018; 616. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Cianciaruso B., Pota A., Bellizzi V., Di Giuseppe D., Di Micco L., Minutolo R. et al. Effect of a Low Versus Moderate-Protein Diet on Progression of CKD: Follow-up of a Randomized Controlled Trial. Am J Kidney Dis 2009; 54(5): 1052–1061. DOI: 10,1053/j.ajkd.2009.07.021</mixed-citation><mixed-citation xml:lang="en">Cianciaruso  B., Pota  A., Bellizzi  V., Di Giuseppe  D., Di Micco  L., Minutolo  R. et  al. Effect of a Low Versus Moderate-Protein Diet on Progression of CKD: Follow-up of a Randomized Controlled Trial. Am J Kidney Dis 2009; 54(5): 1052–1061. DOI: 10,1053/j.ajkd.2009.07.021</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Шайхова Г.И., Отажонов И.О., Рустамова М.Т. Малобелковая диета для больных с хронической болезнью почек. Экспериментальная и клиническая гастроэнтерология 2019;12(172): 135–142.</mixed-citation><mixed-citation xml:lang="en">Shaikhova G.I., Otazhonov I.O., Rustamova  M.T. Low-protein diet for patients with chronic kidney disease. E`ksperimental`naya i klinicheskaya gastroe`nterologiya 2019; 12(172): 135–142. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Завьялова А.Н., Гостимский А.В., Федорец В.Н. Возможности диетотерапии в коррекции нутритивного статуса детей с хронической болезнью почек (обзор литературы). Медицина: теория и практика 2020; 5(1): 50–61.</mixed-citation><mixed-citation xml:lang="en">Zavyalova  A.N., Gostimsky  A.V., Fedorets  V.N. Possibilities of diet therapy in correcting the nutritional status of children with chronic kidney disease (literature review). Meditsina: teoriya i praktika 2020; 5(1): 50–61. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Kramer H. Diet and Chronic Kidney Disease. Adv Nutr 2019; 1: 10(4): 367–379. DOI: 10,1093/advances/nmz011</mixed-citation><mixed-citation xml:lang="en">Kramer H. Diet and Chronic Kidney Disease. Adv Nutr 2019; 1: 10(4): 367–379. DOI: 10,1093/advances/nmz011</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Rysz J., Franczyk B., Ciałkowska-Rysz A., Gluba-Brzózka A. The Effect of Diet on the Survival of Patients with Chronic Kidney Disease. Nutrients 2017; 9(5): 495. DOI: 10,3390/nu9050495</mixed-citation><mixed-citation xml:lang="en">Rysz  J., Franczyk  B., Ciałkowska-Rysz  A., Gluba-Brzózka  A. The Effect of Diet on the Survival of Patients with Chronic Kidney Disease. Nutrients 2017; 9(5): 495. DOI: 10,3390/nu9050495</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
